Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lomas

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|August 2, 2021
The management of Castleman diseaseOliver C Lomas, Matthew Streetly, Guy Pratt, et al.
Immunohematology|January 5, 2013
Molecular background of RH in Bastiaan, the RH:-31,-34 index case, and two novel RHD allelesM E Reid, C H Hipsky, R W Velliquette, et al.
Journal of Immunogenetics|June 1, 1981
The rare Rh haplotypes -D- and --- in a family with A -D-/--- propositusL Kendrick, C Dunstan-Adams, J Humphreys, et al.
Transfusion Medicine (Oxford, England)|April 23, 2002
JAHK: a low frequency antigen associated with the rG complex of the Rh blood group systemC Green, G Coghlan, M Bizot, et al.
Circulation|May 1, 1970
Heterograft valves. An analysis of clinical results of valve replacementM F O'Brien, G H Neilson, E G Galea, et al.
The Biochemical Journal|May 3, 2007
Fibulin-5 binds human smooth-muscle cells through alpha5beta1 and alpha4beta1 integrins, but does not support receptor activationAmanda C Lomas, Kieran T Mellody, Lyle J Freeman, et al.
Leukemia|July 12, 2020
Genome instability in multiple myelomaCarl Jannes Neuse, Oliver C Lomas, Christoph Schliemann, et al.
Ejhaem|July 18, 2022
Validation of clinical-grade whole genome sequencing reproduces cytogenetic analysis and identifies mutational landscape in newly-diagnosed multiple myeloma patients: A pilot study from the 100,000 Genomes ProjectOliver C Lomas, Sarah Gooding, Maite Cabes, et al.
Transfusion|July 1, 1994
FPTT is a low-incidence Rh antigen associated with a "new" partial Rh D phenotype, DFRC Lomas, W Grässmann, D Ford, et al.
Immunohematology|July 4, 2006
Case report:DNA testing resolves unusual results in the Dombrock systemD MacFarland, K Hue-Roye, S Carter, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|August 2, 2021
The management of Castleman diseaseOliver C Lomas, Matthew Streetly, Guy Pratt, et al.
Immunohematology|January 5, 2013
Molecular background of RH in Bastiaan, the RH:-31,-34 index case, and two novel RHD allelesM E Reid, C H Hipsky, R W Velliquette, et al.
Journal of Immunogenetics|June 1, 1981
The rare Rh haplotypes -D- and --- in a family with A -D-/--- propositusL Kendrick, C Dunstan-Adams, J Humphreys, et al.
Transfusion Medicine (Oxford, England)|April 23, 2002
JAHK: a low frequency antigen associated with the rG complex of the Rh blood group systemC Green, G Coghlan, M Bizot, et al.
Circulation|May 1, 1970
Heterograft valves. An analysis of clinical results of valve replacementM F O'Brien, G H Neilson, E G Galea, et al.
The Biochemical Journal|May 3, 2007
Fibulin-5 binds human smooth-muscle cells through alpha5beta1 and alpha4beta1 integrins, but does not support receptor activationAmanda C Lomas, Kieran T Mellody, Lyle J Freeman, et al.
Leukemia|July 12, 2020
Genome instability in multiple myelomaCarl Jannes Neuse, Oliver C Lomas, Christoph Schliemann, et al.
Ejhaem|July 18, 2022
Validation of clinical-grade whole genome sequencing reproduces cytogenetic analysis and identifies mutational landscape in newly-diagnosed multiple myeloma patients: A pilot study from the 100,000 Genomes ProjectOliver C Lomas, Sarah Gooding, Maite Cabes, et al.
Transfusion|July 1, 1994
FPTT is a low-incidence Rh antigen associated with a "new" partial Rh D phenotype, DFRC Lomas, W Grässmann, D Ford, et al.
Immunohematology|July 4, 2006
Case report:DNA testing resolves unusual results in the Dombrock systemD MacFarland, K Hue-Roye, S Carter, et al.
Pageof 9